RAB Diagnostics

RAB Diagnostics

Bioteknologisk forskning

A Predictive Tool for Antibody Drug Conjugates

Om oss

Rab Diagnostics is a Norwegian start-up with the vision to advance personalized cancer medicine with an innovative & proprietary biomarker platform. The platform is designed to predict patients’ response to Antibody Drug Conjugates (ADCs) based on the detection of proteins in the Rab GTPase family.

Bransje
Bioteknologisk forskning
Bedriftsstørrelse
2–10 ansatte
Hovedkontor
Oslo
Type
Privateid selskap
Grunnlagt
2023

Beliggenheter

Ansatte i RAB Diagnostics

Oppdateringer

Tilsvarende sider